AcuCort outlines international expansion plans at Stockholm capital markets day
AcuCort hosted a Capital Markets Day in Stockholm on Oct. 13, outlining its strategy for expansion in Europe and the US. Management highlighted a commercial agreement with Glenmark Pharmaceuticals covering six European markets, targeting launches in 2027. Preparations continue for a US New Drug Application filing for Z